Discontinuation report CUBICIN RF
| Report ID | 266775 |
| Drug Identification Number | 02465493 |
| Brand name | CUBICIN RF |
| Common or Proper name | DAPTOMYCIN FOR INJECTION |
| Company Name | CUBIST PHARMACEUTICALS LLC |
| Market Status | MARKETED |
| Active Ingredient(s) | DAPTOMYCIN |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10 mL Vial |
| ATC code | J01XX |
| ATC description | OTHER ANTIBACTERIALS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2026-06-30 |
| Actual discontinuation date | |
| Remaining supply date | 2026-06-30 |
| Discontinuation status | To be discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | TRIBSCHENSTRASSE 60 6005 LUZERN, LUZERN SWITZERLAND 6005 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-12-30 | French | Compare |
| v3 | 2025-12-30 | English | Compare |
| v2 | 2025-09-08 | French | Compare |
| v1 | 2025-09-08 | English | Compare |
Showing 1 to 4 of 4